As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...

Ozempic (semaglutide) is prescribed for adults with ... Ozempic is given as a weekly dose. Each pen has several doses. The number of doses per pen will depend on the dosage that your doctor ...

Ozempic (semaglutide) is a prescription drug that some doctors may prescribe off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight loss and weight ...

Genetics or hormonal changes can pose challenges for losing weight, as you may know firsthand. Like many others struggling to ...

Ozempic contains the active ingredient semaglutide. (An active ingredient ... contained in prefilled disposable pens. Each pen contains several doses of the medication. They are labeled and ...

Among patients with diabetes and peripheral artery disease, semaglutide 1 mg increased walking distance vs. placebo, ...

Novo Nordisk (NVO) says its obesity drug Ozempic improved walking distance for diabetes patients with peripheral artery ...

A new obesity 'wonder drug’ arrives on the Irish market today. The weight loss medication Wegovy, which is similar to Ozempic ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

SaveHealth explores what the research says about Ozempic's effects on insulin resistance and related conditions.

Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...